The multi-million dollar upgrade and expansion project will be managed by Shawmut Design and Construction and will add 20 high-skilled positions in 2017
PROVIDENCE, RI (December 14, 2016) – Tedor Pharma Inc., a Cumberland-based US pharmaceutical product developer and manufacturer, is expanding and upgrading its large-scale manufacturing facility located at 400 Highland Corporate Drive in Cumberland, Rhode Island. The multi-million dollar project is being managed by Shawmut Design and Construction, a $1.3 billion leading national construction management firm. The expansion project has already broken ground, and is expected to be completed by May of 2017.
The project, which will add approximately 5,400 square feet to the existing 40,000 square-foot facility, will double Tedor’s commercial capacity and capabilities in order to execute on its rapidly-growing product portfolio. As a result of Tedor’s growth, it plans to expand its current high-skilled workforce of 60 employees by adding more than 20 new positions in 2017.
“This investment is in response to our clients’ demand for larger scale, multi-purpose manufacturing capabilities,” said Carl Wooten, CEO/President, Tedor Pharma. “The manufacturing addition and investment in several technologies will double our capacity and will allow us to add sought after high-skilled jobs to the local economy.”
Shawmut will oversee the project, which will include the renovation of 3,300 square-feet of existing space as well as a 2,100 square-foot addition. Modifications within the existing facility footprint will upgrade the space to include several cGMP production suites. The suites will include new equipment to expand capacity and capability, primarily a large-scale 60 cubic-foot V-blender and a state-of-the-art Fluid Bed Processor. Additionally, the suites will include the flexibility to utilize mobile equipment such as high speed tablet presses and encapsulators for solid oral dose manufacturing. The external addition will be utilized to house several key utility systems to feed the Fluid Bed Processor, including a clean-steam boiler, air compressor, and air handling system. The building also has been oversized to accommodate future expansion plans.
“We are excited to team up with Tedor Pharma on this expansion and to contribute to their growth and addition of high-skilled jobs in Rhode Island,” said Les Hiscoe, CEO of Shawmut Design and Construction.
The expansion is phase one of Tedor’s three near-term capital improvements, which are an ongoing strategic effort to expand production capabilities and invest in facilities for new formulations to broaden its customer portfolio.
About Shawmut Design and Construction
Shawmut Design and Construction is a $1.3 billion national construction management firm with a reputation for completing extremely complex and logistically challenging projects for the most high-profile clients in the industry. As an ESOP (employee-owned) company, Shawmut has created a culture of ownership, proactive solution-making, and forward thinking. Eighty percent of its business comes from repeat clients, proving there is a strong focus on building lasting partnerships.
Shawmut’s unique business model allows project teams to better service clients by focusing their specialized expertise within one of the following areas: Academic, Tenant Interiors, Cultural & Historic, Healthcare & Life Sciences, Hotel, Restaurant, Retail, and Sports Venues. Shawmut has offices located in Boston, Providence, New York, Miami, Las Vegas, and Los Angeles. For more information, please visit shawmut.com.
About Tedor Pharma, Inc.
Since 2001, Tedor Pharma has been a leading integrated pharmaceutical manufacturing and research and development company. Tedor offers expertise in drug formulation, development, manufacturing, testing, and commercialization.
Tedor’s winning formula is the ability to take drugs from concept to commercialization, quickly. Tedor’s deep development experience includes 12 FDA approvals, 7 ANDA submissions, and multiple products in the development pipeline. Tedor also offer partners a competitive advantage, via rapid execution, of development and manufacturing services for even the most difficult formulation. In the controlled substance market, Tedor’s full-line Contract Manufacturing Organization consistently delivers high value.
